Cromos™ Pharma helps Regen Biopharma in filing of an Investigational New Drug (IND) application with the FDA

Regen BioPharma announced today filing of an Investigational New Drug (IND) application with the FDA to initiate clinical trials assessing the company’s HemaXellerate I™ stem cell drug in patients with drug-refractory aplastic anemia. Cromos Pharma’s team took active part in IND application preparation.

More details can be found at Regen Biopharma website and press-release.

CONTACT

BD@CROMOSPHARMA.COM

To arrange an introductory meeting and find out how our experience can benefit your next clinical project.

NEWS

EVENTS

Cromos Pharma Names New Head of Feasibility and Therapeutic Strategy
Cromos Pharma Names New Country Head in Poland
Meet Cromos Pharma at the BIO International Convention 2022
Meet Cromos Pharma at ASCO Annual Meeting 2022
Clinical Trials Disrupted During War in Ukraine
Cromos Pharma’s Clinical Research Focus March 2022
Patient recruitment challenges for clinical trials
Key takeaways from Scope 2022
The role of decentralized approaches in clinical trials
7 steps for successful clinical trial protocol design
A new era for clinical trials in Europe
Cromos Pharma launches clinical research focus newsletter
“No Patients – No Payment” risk-sharing program explained
Cromos Pharma on clinical trial trends for 2022
Meet Cromos Pharma at SCOPE 2022
Cromos named top Quality Assurance service provider by Pharma Tech Outlook
Connect with Cromos Pharma at the 40th JP Morgan Healthcare Conference
Cromos Pharma supporting clinical trials to advance HIV treatments
eCONSENT and clinical trials
Cromos Pharma delivering high quality data for clinical trial success
Meet with Cromos Pharma during the San Antonio Breast Cancer Symposium
Unlocking the potential of biosimilars with Cromos Pharma
Cromos Pharma supporting lung cancer clinical trials
Get ready for EU CTR implementation with Cromos Pharma
Cromos Pharma delivering clinical trial success in breast cancer studies
Connect with Cromos Pharma at 40th JP Morgan Healthcare Conference
Cromos Pharma making sure your clinical trial is feasible
Cromos Pharma supporting clinical research to beat heart disease
Conducting clinical trials in the Czech Republic with Cromos Pharma
Cromos Pharma supporting Blood Cancer Awareness Month